2026 Q2 -tulosraportti
24 päivää sitten
‧1 t 2 min
3,75 DKK/osake
Viimeisin osinko
3,96%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·39 min sittenGiven that novo is very cautious with biotech acquisitions and prefers to develop in-house, it might be a good idea to use some of the enormous cash flow to buy back additional shares. At the current share price, it seems attractive to put another 15 billion into a buyback program. They will probably end the year with approximately 130 billion DKK in profit after tax. Of this, approximately 45 billion in dividends and, if it continues, 15 billion in a share program. That is just 60 billion. What will the remaining 70 billion be used for?
In 2024, they spent 16 billion US.$ on buying some complementary factories. A lot of money is being spent on building new factories. I think it's good that they are using the money to invest in the future - instead of paying it out to the shareholders. It's a huge investment that should yield well for the future.
·1 t sittenNovo forum's regular guests 24/7 🤡😂 Why are there actually so many profiles in here who spend almost the entire day telling how terrible Novo is? Fair enough with criticism – there should of course be that. But if you don't own the stock, why spend so much time on a forum for Novo shareholders? 😂 Chipraider, OldBB, Pornoskovl and co. – you've practically become Novo stock's unofficial customer service department. You follow the stock closer than us who actually own it. 😂 Maybe you should buy one Novo stock. Then you at least have a reason to be here 😉 Now I'm going to enjoy the weekend and be happy that I own shares in Novo 🍾 There will be bumps on the road, but I believe 💯 that Novo will come back 🚀📈
Maybe we should just create a standard text we all pasted on every time they start with their l… Imagine they each time get the same message from 10 users, who inform other users about their daily harassment against Novo and others. ?? Then we would avoid getting into the endless discussion that it is, as it absolutely leads to nothing.. just a thought, perhaps build further on the idea yourself..
·1 t sittenGood weekend to all. Here is some relevant reading for a quiet and reflective moment. https://www.dr.dk/nyheder/indland/bekymrende-siger-forsker-om-andelen-af-patienter-der-stopper-paa-wegovyIt's not side effects that are the reason when one reads the information. It's price and incorrect expectation management. Wegovy does what it can/should, but there are certain expectations that once you've lost weight, you can take it from there yourself. Perhaps that's why NN is working on a low-dose pill, which might help maintain weight loss after initial treatment with the doctor. Regardless, the outside world should not expect more than what is stated on the package insert.
·4 t sitten
I think that if it's the first time in 5 years that they recommend selling, while the stock went from 1000kr to 300kr. Then they are probably not the ones I would have trusted the most. But that's just me, I'm generally a bit skeptical.
·10 t sittenI believe that the huge layer of fat, of employees, still needs to be trimmed, and more AI incorporated. The director choice was also unfortunate. We have to go all the way back to Juli/August 2021 for the same share price, it's poorly managed.Go ahead and compare Novo with Eli and see what they revenue per employee, very simply via chat. What does an employee cost nvo vs eli, try to use some neutral glasses
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
24 päivää sitten
‧1 t 2 min
3,75 DKK/osake
Viimeisin osinko
3,96%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·39 min sittenGiven that novo is very cautious with biotech acquisitions and prefers to develop in-house, it might be a good idea to use some of the enormous cash flow to buy back additional shares. At the current share price, it seems attractive to put another 15 billion into a buyback program. They will probably end the year with approximately 130 billion DKK in profit after tax. Of this, approximately 45 billion in dividends and, if it continues, 15 billion in a share program. That is just 60 billion. What will the remaining 70 billion be used for?In 2024, they spent 16 billion US.$ on buying some complementary factories. A lot of money is being spent on building new factories. I think it's good that they are using the money to invest in the future - instead of paying it out to the shareholders. It's a huge investment that should yield well for the future.
- ·1 t sittenNovo forum's regular guests 24/7 🤡😂 Why are there actually so many profiles in here who spend almost the entire day telling how terrible Novo is? Fair enough with criticism – there should of course be that. But if you don't own the stock, why spend so much time on a forum for Novo shareholders? 😂 Chipraider, OldBB, Pornoskovl and co. – you've practically become Novo stock's unofficial customer service department. You follow the stock closer than us who actually own it. 😂 Maybe you should buy one Novo stock. Then you at least have a reason to be here 😉 Now I'm going to enjoy the weekend and be happy that I own shares in Novo 🍾 There will be bumps on the road, but I believe 💯 that Novo will come back 🚀📈Maybe we should just create a standard text we all pasted on every time they start with their l… Imagine they each time get the same message from 10 users, who inform other users about their daily harassment against Novo and others. ?? Then we would avoid getting into the endless discussion that it is, as it absolutely leads to nothing.. just a thought, perhaps build further on the idea yourself..
- ·1 t sittenGood weekend to all. Here is some relevant reading for a quiet and reflective moment. https://www.dr.dk/nyheder/indland/bekymrende-siger-forsker-om-andelen-af-patienter-der-stopper-paa-wegovyIt's not side effects that are the reason when one reads the information. It's price and incorrect expectation management. Wegovy does what it can/should, but there are certain expectations that once you've lost weight, you can take it from there yourself. Perhaps that's why NN is working on a low-dose pill, which might help maintain weight loss after initial treatment with the doctor. Regardless, the outside world should not expect more than what is stated on the package insert.
- ·4 t sittenI think that if it's the first time in 5 years that they recommend selling, while the stock went from 1000kr to 300kr. Then they are probably not the ones I would have trusted the most. But that's just me, I'm generally a bit skeptical.
- ·10 t sittenI believe that the huge layer of fat, of employees, still needs to be trimmed, and more AI incorporated. The director choice was also unfortunate. We have to go all the way back to Juli/August 2021 for the same share price, it's poorly managed.Go ahead and compare Novo with Eli and see what they revenue per employee, very simply via chat. What does an employee cost nvo vs eli, try to use some neutral glasses
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
2026 Q2 -tulosraportti
24 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 5.8. | ||
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 |
3,75 DKK/osake
Viimeisin osinko
3,96%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·39 min sittenGiven that novo is very cautious with biotech acquisitions and prefers to develop in-house, it might be a good idea to use some of the enormous cash flow to buy back additional shares. At the current share price, it seems attractive to put another 15 billion into a buyback program. They will probably end the year with approximately 130 billion DKK in profit after tax. Of this, approximately 45 billion in dividends and, if it continues, 15 billion in a share program. That is just 60 billion. What will the remaining 70 billion be used for?In 2024, they spent 16 billion US.$ on buying some complementary factories. A lot of money is being spent on building new factories. I think it's good that they are using the money to invest in the future - instead of paying it out to the shareholders. It's a huge investment that should yield well for the future.
- ·1 t sittenNovo forum's regular guests 24/7 🤡😂 Why are there actually so many profiles in here who spend almost the entire day telling how terrible Novo is? Fair enough with criticism – there should of course be that. But if you don't own the stock, why spend so much time on a forum for Novo shareholders? 😂 Chipraider, OldBB, Pornoskovl and co. – you've practically become Novo stock's unofficial customer service department. You follow the stock closer than us who actually own it. 😂 Maybe you should buy one Novo stock. Then you at least have a reason to be here 😉 Now I'm going to enjoy the weekend and be happy that I own shares in Novo 🍾 There will be bumps on the road, but I believe 💯 that Novo will come back 🚀📈Maybe we should just create a standard text we all pasted on every time they start with their l… Imagine they each time get the same message from 10 users, who inform other users about their daily harassment against Novo and others. ?? Then we would avoid getting into the endless discussion that it is, as it absolutely leads to nothing.. just a thought, perhaps build further on the idea yourself..
- ·1 t sittenGood weekend to all. Here is some relevant reading for a quiet and reflective moment. https://www.dr.dk/nyheder/indland/bekymrende-siger-forsker-om-andelen-af-patienter-der-stopper-paa-wegovyIt's not side effects that are the reason when one reads the information. It's price and incorrect expectation management. Wegovy does what it can/should, but there are certain expectations that once you've lost weight, you can take it from there yourself. Perhaps that's why NN is working on a low-dose pill, which might help maintain weight loss after initial treatment with the doctor. Regardless, the outside world should not expect more than what is stated on the package insert.
- ·4 t sittenI think that if it's the first time in 5 years that they recommend selling, while the stock went from 1000kr to 300kr. Then they are probably not the ones I would have trusted the most. But that's just me, I'm generally a bit skeptical.
- ·10 t sittenI believe that the huge layer of fat, of employees, still needs to be trimmed, and more AI incorporated. The director choice was also unfortunate. We have to go all the way back to Juli/August 2021 for the same share price, it's poorly managed.Go ahead and compare Novo with Eli and see what they revenue per employee, very simply via chat. What does an employee cost nvo vs eli, try to use some neutral glasses
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt